全球家庭医疗保健软件市场 – 行业趋势和 2030 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球家庭医疗保健软件市场 – 行业趋势和 2030 年预测

  • Healthcare
  • Upcoming Report
  • Dec 2022
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Global Home Healthcare Software Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2030
Diagram Market Size (Base Year)
USD 10.30 Billion
Diagram Market Size (Forecast Year)
USD 20.37 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

全球家庭医疗保健软件市场,按设备(监测设备、治疗设备、移动辅助设备等)、部署(本地、基于网络、基于云)、模式(个人电脑/笔记本电脑、手持设备/智能手机)、服务(康复、输液治疗、呼吸治疗、孕期护理、专业护理、姑息治疗、其他)、软件(代理软件、临床管理系统、临终关怀解决方案应用程序、远程医疗解决方案)、最终用户(家庭护理机构、临终关怀、私人值班机构、康复中心/治疗中心)划分——行业趋势和预测到 2030 年。

家庭医疗保健软件市场

 家庭医疗保健软件市场分析和规模

根据美国劳工统计局的数据,2010 年至 2020 年间,家庭健康助理和个人护理助理的数量预计将增加 70%,达到 1300 万人。市场驱动因素包括人口老龄化、目标疾病发病率上升以及日益需要减少医疗支出作为一项经济上可行的举措。由于慢性病患病率上升,预计治疗费用将在预测期内稳步上升。这种个性化护理是一种控制治疗成本的低成本解决方案,也是该行业的高影响力驱动因素。

Data Bridge Market Research 分析,家庭医疗保健软件市场在 2022 年的规模为 103 亿美元,预计到 2030 年将达到 203.7 亿美元,在 2023 年至 2030 年的预测期内复合年增长率为 8.9%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。

家庭医疗保健软件市场范围和细分      

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021(可定制为 2015 - 2020)

定量单位

收入(单位:十亿美元)、销量(单位:台)、定价(美元)

涵盖的领域

设备(监测设备、治疗设备、移动辅助设备、其他)、部署(本地、基于网络、基于云)、模式(个人电脑/笔记本电脑、手持设备/智能手机)、服务(康复、输液治疗、呼吸治疗、孕期护理、专业护理、姑息治疗、其他)、软件(机构软件、临床管理系统、临终关怀解决方案应用程序、远程医疗解决方案)、最终用户(家庭护理机构、临终关怀、私人值班机构、康复中心/治疗中心)

覆盖国家

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Koninklijke Philips N.V. (Netherlands), Omron Healthcare, Inc. (Japan), Air Liquide (France), B. Braun SE (Germany), Medtronic (Ireland), Davita Inc. (U.S), CARDINAL HEALTH (U.S), Sunrise Medical (U.S), A&D Company, Limited (Japan), BAYADA Home Health Care (U.S), Invacare Corporation (U.S), Philips Healthcare (Netherlands), Fresenious SE & Co KGaA (Germany), General Electric Company (U.K.), Baxter (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Bupa Home Healthcare, Ltd (U.K.), Healthcare at Home (U.K.) and Linde plc (Germany)

Market Opportunities

  • Rise in demand for hospice care

Market Definition

Home healthcare software provides a wide range of home healthcare services to treat a variety of illnesses and injuries. It is the result of digital healthcare operations, and its adoption in healthcare is increasing at an impressive rate due to benefits such as cost-effectiveness, convenience, and high quality home care services and treatment. Home healthcare software can be accessed via PC/Laptop or handheld devices/smartphones. Home healthcare services include skilled medical professionals, physical therapy, occupational therapy, speech therapy, and a variety of other services. The rising prevalence of diseases such as cardiovascular, metabolic, Parkinson's, infectious (HIV/AIDS), and others has increased demand for home healthcare. Home healthcare refers to rehabilitation services provided in a patient's home, such as skilled nursing, physical therapy, and occupational therapy.

Home Healthcare Software Market Dynamics

Drivers

  • Rising geriatric population

The global population is rapidly ageing as a result of lower birth rates and increased life expectancy, which may result in a high prevalence of chronic diseases as the older population is more susceptible to chronic diseases due to ageing and low immunity, creating demand for home healthcare services and software. According to the World Health Organization's October 2021 report, the global population of people aged 60 and up is expected to increase from 1 billion in 2020 to 2.1 billion by 2050, which is expected to have a significant impact on the home healthcare software market, as older people become more reliant on others for care and other needs.

  • New product development and launches

New product development and launches by market players in the area are expected to boost market growth. For instance, in May 2020, Homecare HomebaseSM (HCHB) partnered with MUSE Healthcare of St. Paul to provide improved hospice care during the most critical stages of a patient's care journey. The new product improves predictions, preparations, and offers for hospice patients in their final 7-12 days of life using sophisticated modeling and machine learning. As a result of the aforementioned factors, the hospice software solution segment is expected to account for a sizable share of the home healthcare software market during the forecast period.

Opportunities

  • Rise in demand for hospice care

The demand for hospice care has recently increased and is expected to remain high due to an ageing population and an increase in the incidence of life-threatening diseases such as cancer. According to the Eurostat July 2020 update, it is estimated that by 2050, there will be approximately half a million centenarians in the European Union, and the median age of the European Union-27 region is expected to increase by 4.5 years to 48.2 years. As a result, the ageing population is expected to play a significant role in the growth of the studied segment. As a result, the ageing population is expected to play a significant role in the growth of the studied segment. Further, according to the data published by Globocan 2020, there were approximately 19.29 million globally suffering from cancer globally in 2020 and the incidence of cancer is expected to increase to 28.89 million by 2040. This factor is expected to increase demand for hospice care centres, which in turn will increase demand for home healthcare software.

Restraints/Challenges

  • High cost

The implementation cost, limited insurance coverage, and patient safety concerns may pose significant challenges to the market's growth.

This home healthcare software market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the home healthcare software market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Home Healthcare Software Market

COVID-19 疫情在全球爆发,导致整个医疗保健行业的负担意外增加,因为感染风险增加导致医院就诊人数大幅减少。这迫使各医疗保健机构和政府机构对远程医疗和其他虚拟医疗解决方案进行大量投资。对这些解决方案的日益青睐预计将在未来几年推动家庭医疗保健软件市场的增长。

最新动态

  • 2020 年,Simione Healthcare Consultants, LLC 和 Home Health Solutions, LLC 宣布达成合并协议,合作提供家庭和社区护理的咨询和编码服务。
  • 2020 年,Healthcare Provider Solutions 宣布收购了家庭护理和临终关怀编码和临床咨询提供商 5 Star Consultants LLC。由于上述因素,北美家庭医疗保健软件市场预计将在预测期内大幅增长。

全球家庭医疗保健软件市场范围

家庭医疗保健软件市场根据设备、部署、模式、服务、软件和最终用户进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。

设备

  • 监控设备
  • 治疗设备
  • 移动辅助
  • 其他的

 部署

  • 本地部署
  • 基于网络
  • 基于云

 模式

  • 个人电脑/笔记本电脑
  • 手持设备/智能手机

 服务

  • 康复
  • 输液治疗
  • 呼吸治疗
  • 孕期护理
  • 专业护理
  • 姑息治疗
  • 其他的

 软件

  • 代理软件
  • 临床管理系统
  • 临终关怀解决方案应用
  • 远程医疗解决方案

 最终用户

  • 家庭护理机构
  • 临终关怀
  • 私人职责机构
  • 康复中心/治疗中心

家庭医疗保健软件市场区域分析/见解

对家庭医疗保健软件市场进行了分析,并按国家、设备、部署、模式、服务、软件和最终用户提供了市场规模洞察和趋势。

家庭医疗保健软件市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

由于拥有大量参与者且医疗机构拥有先进的 IT 基础设施,北美在家庭医疗保健软件市场占据主导地位。

由于技术和医疗设施的快速增长以及人口基数高,预计亚太地区将在 2023 年至 2030 年的预测期内以最高的增长率增长。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

家庭医疗保健软件市场还为您提供每个国家/地区资本设备医疗保健支出增长、家庭医疗保健软件市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗保健监管情景的变化及其对家庭医疗保健软件市场的影响的详细市场分析。数据涵盖 2011-2021 年的历史时期。

竞争格局和家庭医疗保健软件市场份额分析

家庭医疗保健软件市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对家庭医疗保健软件市场的关注有关。

家庭医疗保健软件市场的一些主要参与者包括:

  • Koninklijke Philips NV(荷兰)
  • 欧姆龙医疗股份有限公司(日本)
  • 液化空气集团(法国)
  • B. Braun SE(德国)
  • 美敦力(爱尔兰)
  • Davita Inc.(美国)
  • 康德乐(美国)
  • Sunrise Medical(美国)
  • 通用电气公司(美国)
  • A&D 有限公司 (日本)
  • BAYADA 家庭保健(美国)
  • Invacare 公司 (美国)
  • 飞利浦医疗保健(荷兰)
  • Fresenious SE & Co KGaA(德国)
  • 百特(美国)
  • F. Hoffmann-La Roche Ltd(瑞士)
  • Bupa Home Healthcare, Ltd(英国)
  • 家庭医疗保健(英国)
  • 林德公司 (德国)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The home healthcare software market size will be worth USD 20.37 billion by 2030.
The growth rate of the home healthcare software market is 8.9% in the forecast period by 2030.
The rising geriatric population and new product development and launches are the growth drivers of the home healthcare software market.
Equipment, deployment, mode, service, software, and end-user are the factors on which the home healthcare software market research is based.
Major companies in the home healthcare software market are Koninklijke Philips N.V. (Netherlands), Omron Healthcare, Inc. (Japan), Air Liquide (France), B. Braun SE (Germany), Medtronic (Ireland), Davita Inc. (U.S), CARDINAL HEALTH (U.S), Sunrise Medical (U.S), A&D Company, Limited (Japan), BAYADA Home Health Care (U.S), Invacare Corporation (U.S), Philips Healthcare (Netherlands), Fresenious SE & Co KGaA (Germany), General Electric Company (U.K.), Baxter (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Bupa Home Healthcare, Ltd (U.K.), Healthcare at Home (U.K.) and Linde plc (Germany)